Results 91 to 100 of about 7,629 (157)

Comparison of various regimens of itraconazole in treatment of acute vulvovaginal candidiasis

, 2021
Dhiraj Dhoot, Piyush Prabhat, Lalita Mayadeo, Harshal Mahajan   +3 more
openalex   +2 more sources

Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis? [PDF]

, 2022
Gabriela Corrêa Carvalho, Gabriel Davi Marena, Gabriela Ricci Leonardi, Rafael Miguel Sábio, Ione Corrêa, Marlus Chorilli, Taís Maria Bauab   +6 more
openalex   +1 more source

Human Als3p Antibodies are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis [PDF]

, 2018
Priya Uppuluri, Shakti Singh, Abdullah Alqarihi, Clint S. Schmidt, John P. Hennessey, Michael R. Yeaman, Scott G. Filler, John E. Edwards, Ashraf S. Ibrahim   +8 more
openalex   +1 more source

Identification of Candida Species Using Phenotypic and Molecular Methods Isolated from Women Infected with Vulvovaginal Candidiasis in Maysan, Iraq

, 2022
Khutam J. Hassan, Ali A. Kasim
openalex   +1 more source

Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: A retrospective study of 954,186 patients

, 2018
Louis Jacob, Mara John, Matthias Kalder, Karel Kostev   +3 more
openalex   +1 more source

VULVOVAGINAL CANDIDIASIS IN COMBINATION WITH BACTERIAL VAGINOSIS IN WOMEN OF REPRODUCTIVE AGE: FEATURES OF PATHOGENESIS AND TREATMENT

, 2021
Svitlana Pandei, Dmytro Ledin, Oleksandra Lubkovska   +2 more
openalex   +2 more sources

Vaginal chlorhexidine gluconate versus fluconazole for recurrent vulvovaginal candidiasis: A randomized noninferiority trial. [PDF]

PLoS One
Alvendal C, Hasselrot T, Balduck M, Edfeldt G, Schuppe-Koistinen I, Brauner A, Altman D, Broliden K, Bohm-Starke N.   +8 more
europepmc   +1 more source

Inhibition of CXCR4 by MicroRNA-1192 Reduces the Activation of Th17 Cells and Expression of Inflammation Factors in a Mouse Model of Vulvovaginal Candidiasis [PDF]

, 2018
Jing Liu, Huaizhen Wang, Yong Sun
openalex   +1 more source

Oteseconazole (VIVOJA) for prevention of recurrent vulvovaginal candidiasis

, 2022
Giel Vanreppelen, Jana Nysten, Silke Baldewijns, Mart Sillen, Gilbert Donders, Patrick Van Dijck   +5 more
openalex   +2 more sources

Perspectives on Vaginal Ecology and Management of Recurrent Vulvovaginal Candidiasis: A Narrative Review. [PDF]

J Fungi (Basel)
Grando D, Watson CJ.
europepmc   +1 more source